iBio Inc (IBIO)
2.64
+0.19
(+7.76%)
USD |
NYAM |
Nov 22, 16:00
2.64
0.00 (0.00%)
Pre-Market: 20:00
iBio Free Cash Flow: -16.93M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -16.93M |
| June 30, 2024 | -18.55M |
| March 31, 2024 | -18.67M |
| December 31, 2023 | -18.89M |
| September 30, 2023 | -21.82M |
| June 30, 2023 | -36.17M |
| March 31, 2023 | -45.63M |
| December 31, 2022 | -49.98M |
| September 30, 2022 | -52.21M |
| June 30, 2022 | -49.11M |
| March 31, 2022 | -43.96M |
| December 31, 2021 | -44.30M |
| September 30, 2021 | -40.91M |
| June 30, 2021 | -35.23M |
| March 31, 2021 | -30.13M |
| December 31, 2020 | -25.65M |
| September 30, 2020 | -19.84M |
| June 30, 2020 | -14.50M |
| March 31, 2020 | -14.38M |
| December 31, 2019 | -14.77M |
| September 30, 2019 | -16.22M |
| June 30, 2019 | -14.96M |
| March 31, 2019 | -14.06M |
| December 31, 2018 | -13.77M |
| September 30, 2018 | -12.50M |
| Date | Value |
|---|---|
| June 30, 2018 | -14.56M |
| March 31, 2018 | -15.19M |
| December 31, 2017 | -15.07M |
| September 30, 2017 | -15.01M |
| June 30, 2017 | -14.76M |
| March 31, 2017 | -13.35M |
| December 31, 2016 | -11.92M |
| September 30, 2016 | -9.85M |
| June 30, 2016 | -8.14M |
| March 31, 2016 | -6.528M |
| December 31, 2015 | -5.466M |
| September 30, 2015 | -5.504M |
| June 30, 2015 | -4.94M |
| March 31, 2015 | -4.413M |
| December 31, 2014 | -4.381M |
| September 30, 2014 | -4.006M |
| June 30, 2014 | -4.375M |
| March 31, 2014 | -4.578M |
| December 31, 2013 | -4.526M |
| September 30, 2013 | -4.666M |
| June 30, 2013 | -5.044M |
| March 31, 2013 | -5.198M |
| December 31, 2012 | -6.926M |
| September 30, 2012 | -6.282M |
| June 30, 2012 | -6.255M |
Free Cash Flow Range, Past 5 Years
-52.21M
Minimum
Sep 2022
-14.38M
Maximum
Mar 2020
-30.58M
Average
-27.89M
Median
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| Theriva Biologics Inc | -18.84M |
| Oragenics Inc | -7.682M |
| Nanoviricides Inc | -7.934M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.715M |
| Cash from Investing (Quarterly) | 0.713M |
| Cash from Financing (Quarterly) | -0.162M |
| Free Cash Flow Per Share (Quarterly) | -0.4303 |
| Free Cash Flow Yield | -112.4% |